Ardelyx Inc ARDX

NAS: ARDX | ISIN: US0396971071 24/04/2024

6,430 USD (+0,63%)

(+0,63%) 24/04/2024

Grafiek Ardelyx Inc

Grafiek Ardelyx Inc

1 dag1d 0,63%
1 week1w -0,16%
1 maand1m -16,49%
3 maanden3m -27,67%
6 maanden6m 81,13%
1 jaar1j 39,48%
5 jaar5j 93,67%

donderdag 2 mei 2024, 22:00

Kwartaalcijfers (1ste kwartaal)

Ardelyx Inc in het nieuws

Toon enkel gratis nieuws

25 oktober 2023 · Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance? · Persbericht

24 oktober 2023 · Thinking about buying stock in VinFast Auto, Ardelyx, Harpoon Therapeutics, Mind Technology, or Ault Alliance? · Persbericht

20 oktober 2023 · Thinking about buying stock in Ardelyx, Rivian Automotive, Femasys, Lucid Group, or Outlook Therapeutics? · Persbericht

19 oktober 2023 · Thinking about buying stock in Ardelyx, RVL Pharmaceuticals, Wheeler Real Estate Investment Trust, Troika Media Group, or AT&T? · Persbericht

18 oktober 2023 · Thinking about buying stock in Tempest Therapeutics, VinFast Auto, AGNC Investment, Ardelyx, or Viking Therapeutics? · Persbericht

2 februari 2023 · Ardelyx, Inc. Reports Employment Inducement Grants · Persbericht

29 december 2022 · FDA Grants Appeal for Ardelyx's XPHOZAH® (tenapanor) · Persbericht

23 december 2022 · Ardelyx, Inc. Reports Employment Inducement Grants · Persbericht

17 december 2022 · Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis · Persbericht

22 november 2022 · Ardelyx to Present at the 34th Annual Piper Sandler Healthcare Conference · Persbericht

Profiel Ardelyx Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.ardelyx.com

Hoofdzetel: Fremont, California Verenigde Staten

CEO: Michael Raab

Werknemers: 200

Aandelen Ardelyx Inc

Beurswaarde: 1,49 miljard USD

Effecten: 232,69 miljoen

Beta: 1,40

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe